Charles River Laboratories International (CRL) Gross Margin (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Gross Margin of 74.93% for Q4 2025, up 11114.0% year-over-year from N/an in Q4 2024, and up 26.17% on a QoQ basis from 59.39% in Q3 2025.
Charles River Laboratories International (CRL) Gross Margin (2009 - 2025) Analysis & Trends
Charles River Laboratories International (CRL) has reported Gross Margin for 17 consecutive years, with 74.93% the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Margin rose 11114.0% year-over-year to 74.93%; the TTM figure through Dec 2025 stood at 54.68% (up 1638.0% YoY), while the FY2025 annual figure was 85.65%, up 2755.0% from the prior year.
- Gross Margin came in at 74.93% for Q4 2025 at Charles River Laboratories International, up from 59.39% in the prior quarter.
- The five-year high for Gross Margin was 210.64% in Q4 2021, with the low at 36.22% in Q4 2024.
- Average Gross Margin over 5 years is 60.88%, with a median of 47.66% recorded in 2021.
- Across the five-year window, Gross Margin slumped 16548 bps in 2022 and surged 11114 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 210.64% in 2021, then plunged by 79 bps to 45.16% in 2022, then surged by 52 bps to 68.57% in 2023, then slumped by 153 bps to 36.22% in 2024, then surged by 307 bps to 74.93% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 74.93%, 59.39%, and 43.33% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 63.35% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 99.91% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 53.95% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 32.64% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 58.68% |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn | 74.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 74.93% |
| Sep 27, 2025 | 59.39% |
| Jun 28, 2025 | 43.33% |
| Mar 29, 2025 | 41.33% |
| Dec 28, 2024 | -36.22% |
| Sep 28, 2024 | 86.34% |
| Jun 29, 2024 | 43.73% |
| Mar 30, 2024 | 58.69% |
| Dec 30, 2023 | 68.57% |
| Sep 30, 2023 | 35.25% |
| Jul 1, 2023 | 37.64% |
| Apr 1, 2023 | 36.69% |
| Dec 31, 2022 | 45.16% |
| Sep 24, 2022 | 91.08% |
| Jun 25, 2022 | 46.29% |
| Mar 26, 2022 | 46.73% |
| Dec 25, 2021 | 210.64% |
| Sep 25, 2021 | 89.95% |
| Jun 26, 2021 | 89.52% |
| Mar 27, 2021 | 48.58% |